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Abstract
Postoperative nausea and vomiting (PONV) continues to occur despite medical
advances over the years. PONV decreases patient satisfaction, can lead to postoperative
complications such as dehydration and suture dehiscence, and it increases hospital costs.
Evidence in the literature suggests a preoperative risk assessment screening and prophylactic
antiemetic administration can decrease the incidence of PONV. The purpose of this project
was to evaluate the effectiveness of a risk assessment tool and to determine if the tool would
decrease the incidence of PONV. This quality improvement project involved collecting preintervention PONV data over a 6-week time period. The pre-intervention incidence was 17%
(n=12). A risk assessment tool was implemented in the perioperative surgical home area of
the hospital where presurgical telephonic assessments were completed. Post intervention
data was collected with regard to PONV incidence over a 6-week time period, resulting in an
incidence of 19% (n=16). No significant findings were established as a result from this
quality improvement project. It is recommended to perform a similar quality improvement
project with a larger sample size to achieve statistical significance as well as decrease the rate
of PONV.
Keywords: postoperative nausea and vomiting, Apfel’s simplified risk score, risk
assessment tool, postoperative complications
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Chapter 1
Postoperative Nausea and Vomiting (PONV) occurs in 10-80% of surgical patients
(Smith, Haas, Zepp, & Klein, 2016). Seventy percent of those patients are assessed to be a
high risk for PONV, which can often lead to post-surgical complications (Thomas, Maple,
Norcross, & Muckler, 2019). The implementation of a PONV risk prediction and
prophylaxis protocol can be implemented to be patient specific and tailored to the patient’s
risk factors and needs, leading to improved patient satisfaction and most importantly, a
decrease in the incidence of PONV.
Background
Risk factors for PONV can be difficult to pinpoint; however, various factors have
been identified to increase one’s risk. Gender, age, length of surgical procedure, genetics,
and type of anesthetic used have all been linked with PONV (Squire & Spencer, 2018). The
female gender carries a threefold increased risk for developing PONV (Squire & Spencer,
2018). Additionally, gynecological surgery itself is considered a risk factor because of both
the female patient group and the length of surgeries (Squire & Spencer, 2018).
Prevention of PONV post-surgery can help increase patient satisfaction, improve
healing time, and decrease length of stay (Smith & Ruth-Sahd, 2016). A consistent method
to identify who is at risk for PONV can provide an effective treatment regimen. Assessing
patients in preadmission testing can ensure the patient is identified before the onset of
surgery and treated respectively. Additionally, patients who are a low risk for PONV can
avoid exposure to antiemetic medications, which come with their own risks (Thomas, et al.,
2019).
Risk assessment tools have been implemented in various studies to evaluate their
effectiveness on the decrease of PONV. In a study performed by Thomas, et al. (2019), the
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number of prophylactic antiemetics administered increased after the implementation of the
risk prediction and prophylaxis tool. The incidence of PONV decreased from 32.3% to
28.9%, while the antiemetic compliance increased from 37% pre-implementation to 61%
postimplementation (Thomas et al., 2019). In another study by Roberts, Barclay, and Scott
(2010), researchers compared the use of a risk measurement tool versus anesthetists’
subjective patient assessment. The risk assessment tool identified 51% of a group of
gynecological patients were at a high risk for PONV, while the anesthetists’ assessments only
identified 25% of the same group of patients to be at a high risk.
Impact of PONV on Patient Care
PONV impacts not only patient care outcomes, but also costs to a hospital or clinical
setting. For those who experience PONV, these patients spend twice as long in the post
anesthesia care unit (PACU) as compared to those who do not experience PONV (Thomas et
al., 2019). The delay in discharge from the PACU impacts perioperative efficiency and
disrupts the flow of patients from the operating room to the PACU, causing delays in care
and compromising patient safety (Thomas et al., 2019).
PONV can impact the patient directly by resulting in poor quality of recovery and
postoperative complications. Dehydration, electrolyte imbalance, pulmonary aspiration,
suture dehiscence, and pneumothorax are all possible complications in the post-operative
period (Smith et al., 2016 & Thomas et al., 2019). PONV also causes anxiety for patients
preoperatively, with patients ranking PONV as the most undesirable postoperative outcome
(Thomas et al., 2019).
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Gap/Purpose
Though there is evidence that the utilization of a PONV risk prediction and
prophylaxis protocol can be successful, there is a need to perform more quality improvement
projects and to prove its benefits. Because of this need, the primary investigator proposed a
retrospective pre- and post-implementation quality improvement project. The designated
hospital where the project took place did not utilize a risk assessment tool in its entirety.
Patients were being screened for gender and a history of non-smoking status, but they were
not being screened for a history of motion sickness/history of PONV. A thorough risk
assessment tool addresses four predictors of PONV: female gender, history of motion
sickness or PONV, non-smoking status, and planned use of opioids postoperatively (Apfel,
Laara, Koivuranta, Greim, & Roewer, 1999). Patients were not specifically asked the
predictor of planned use of postoperative opioids, as this is a decision for providers caring for
the patient post-surgery.
In order to capture the risk score for PONV, the hospital created an algorithm within
the electronic health record (EHR). As risk factors were identified, they were entered into
the EHR. Because motion sickness was not being addressed within the screening phone call,
the calculated score at the time of the prescreening phone call was incomplete. It was
unclear if patients were a low, moderate, or high risk for PONV at this point in the presurgery screening. Additionally, nurses were not communicating the PONV risk score to
providers. The purpose of this quality improvement project was to decrease the incidence of
postoperative nausea and vomiting by fully implementing a PONV risk assessment tool,
specifically inquiring about a history of motion sickness, and communicating that risk score
to providers.
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Clinical Questions
In scheduled surgical patients (P), how does the use of a risk assessment tool in its
entirety (I), compared to current practice of not utilizing the entire risk assessment tool (C),
affect the incidence of postoperative nausea and vomiting (O) within a 6-week time period
(T)?
1.

Does adding motion sickness to the prescreening phone calls decrease PONV rates?

2. Does identifying high risk patients during the prescreening phone call phase decrease
PONV rates?
Project Objectives
•

Examine whether the current practice of prescreening questions will need to
be amended based on the results of this project.

•

Determine if the full risk assessment tool should or should not be
implemented at the hospital.

•

Improve patient care outcomes by conducting a thorough risk assessment for
PONV.

•

Improve patient care outcomes by communicating PONV risk scores to
providers.

Methodology
The project used a retrospective pre- and post- implementation quality improvement
design. The data for this project was extracted from the electronic health record (EHR)
where it was documented if the patient experienced nausea and/or vomiting in the post
anesthesia care unit (PACU). The data extracted during the pre-implementation phase
provided a baseline of PONV incidence. After pre implementation data was collected,
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introduction of the full Apfel Simplifed Risk Score for PONV, including a history of motion
sickness, was introduced to the staff in the perioperative surgical home department.
Educational sessions were held for nursing staff regarding the use and implementation of the
tool. The post implementation data was extracted similarly to the pre implementation phase.

5

Chapter 2
The Literature Review will discuss studies and quality improvement projects on
postoperative nausea and vomiting (PONV) and the use of a risk assessment tool and
prophylaxis protocol. Additionally, a theoretical framework will be explored, specifically its
relation to this quality improvement project. The review is divided into the following
sections: a) terms and concept definitions b) theoretical framework, c) review of literature,
(d) summary and research gaps, and (e) purpose statement.
Term/Concept Definitions
For the purposes of this quality improvement project, postoperative nausea and
vomiting is defined as nausea and vomiting that occurs within the first 24-hour period after
surgery (American Society of PeriAnesthesia Nurses [ASPAN], 2006). Nausea is a selfreport of an unpleasant feeling in the epigastrium or the back of the throat (ASPAN, 2006).
Some patient descriptors include, but are not limited to “feeling sick to my stomach” and
“feeling queasy” (ASPAN, 2006). Vomiting, as defined by ASPAN (2006), is the forceful
expulsion of the contents of the stomach, duodenum, and jejunum through the oral cavity.
Prophylaxis is defined as the use of antiemetic medications before the onset of symptoms of
PONV. Risk factor refers to an independent predictor of a future occurrence of an event or
incident (ASPAN, 2006). Rescue antiemetics are defined as antiemetic medications that are
used after the onset of nausea and vomiting postoperatively.
Theoretical Framework
Postoperative nausea and vomiting can be one’s response to environmental factors
such as the type of anesthesia used, being a non-smoker, a history of PONV or motion
sickness, and postoperative opioid use. Female gender is another risk factor that can lead to
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PONV. Neuman Systems Model was used as the theoretical framework because it focused
on client system wellness and environmental stressors that threaten one’s optimal system
stability (Fawcett, 2017). In this quality improvement project, the goal was for the client to
maintain wellness, despite environmental stressors and one’s response to those stressors.
Optimal system stability is described as the best possible wellness state of an individual at
any given time (Neuman & Fawcett, 2011). Neuman Systems Model is a holistic and
system-based approach to the person and their response to actual or potential environmental
stressors (Fawcett, 2017). There are various components of the systems model. Prevention
as Intervention was chosen because it correlates with the risk assessment and prophylaxis
protocol regarding PONV (Figure 1). The model has three types of prevention that promote
wellness: primary, secondary, and tertiary (Neuman & Fawcett, 2011). Reducing risk factors
and preventing identified or suspected stressors before the client experiences them, also
known as retaining wellness, is the first step of Neuman’s model (Zaccagnini & White,
2017). Assessing all patients to identify if they may be at risk for PONV will fall under the
primary type of prevention. In the secondary prevention phase, the goal is to intervene in
order to strengthen internal resistance to stressors (Neuman & Fawcett, 2011). Here, the
implementation of the prophylactic antiemetics would take place. Lastly, the tertiary
prevention phase is defined as the protection of the wellness that was attained from the
secondary prevention and support the client’s strengths and energy reserves (Neuman &
Fawcett, 2011). This phase supports the patient’s wellness they attained from having the
prophylactic antiemetics and supports the patient during the acute recovery phase.
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Review of Literature
A detailed review of literature was conducted using CINAHL, Google Scholar, and
MEDLINE. The key words, or search terms, used included postoperative nausea and
vomiting, postoperative nausea and vomiting risk assessment, risk of postoperative nausea
and vomiting, and postoperative nausea and vomiting prophylaxis. The inclusion criteria
included the primary language as English, peer reviewed, and published between 2009 and
2019. Exclusion criteria were studies that had a narrow focus on specific antiemetic drugs as
prophylaxis; studies that did not primarily involve PONV; and studies where the patient
population was primarily pediatric. A total of 12 articles were selected based on the
relevance of topic to this literature review. These articles included literature reviews to
assess any gaps in research, implementation of quality improvement projects to support and
provide evidence to the topic, and multivariable analyses to determine the effectiveness of
risk assessment tools.
According to the findings from the articles selected, utilization of a risk assessment
and prophylactic protocol yielded a number of benefits. Common findings include a
decrease in PONV comparing pre-implementation and post-implementation groups,
identification of risk factors, the use of simplified risk scores, and compliance by anesthesia
providers of an antiemetic prophylaxis protocol (Tabrizi, Malhotra, Turnbull, & Goode,
2019; Smith, Haas, Zepp, & Klein, 2016; Thomas, Maple, Norcross, & Muckler, 2019)).
When referring to identification of risk factors for PONV, studies showed that various
factors can lead to PONV, including patients’ gender and age, anesthetics used, and surgical
variables, such as type of surgery (Kim et al., 2013). Apfel’s simplified risk score for
predicting PONV consists of four risk factors: female gender, nonsmoking history, history of
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PONV or motion sickness, and the use of postoperative opioids. Female gender is identified
as a significant risk factor for PONV. According to Smith & Ruth-Sahd (2016) and Collins
(2019), females have more than a two and a half times greater chance of experiencing PONV
regardless of age or menstrual status. By identifying individuals at high risk for PONV,
those at low risk can be eliminated from being treated with prophylactic antiemetic therapy
(Chatterjee, Rudra, & Sengupta, 2011; Apfel et al., 2012).
Simplified risk scores have been both reliable and valid in identifying risk factors and
providing appropriate antiemetics (Pierre & Whelan, 2013). The most commonly found and
used risk scores are Apfel’s Simplified Risk Score and Koivuranta Simplified Risk Score.
Studies have supported the use of the latter scores in that they are simple, containing between
four and five risk factors, both identifying the higher the score, the higher the risk of PONV
(Apfel et al., 2012; Smith et al., 2016). Studies have shown that with the use of the
simplified risk scores, anesthesia providers can be presented with a PONV risk score
accompanied with recommendations on the number of prophylactic antiemetics to administer
based on that individual’s risk (Kappen et al., 2015; smith Merckx, Peuch, Necib, & Pingeon,
2010). Because the steps are simplified and recommendations are provided directly to the
anesthesia provider, compliance of the screening tool and prophylaxis protocol has been
reached (Tabrizi et al., 2019). With proper screening and proper administration of
antiemetics, studies have shown a decrease in PONV and improved patient satisfaction
(Tabrizi et al., 2019; Smith et al., 2016; Sigaut et al., 2010).
Summary and Research Gaps
Research has proven that with the use of a simplified risk score and prophylactic
protocol, reduction in PONV is possible and compliance by providers can be achieved.
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Patients reported a decrease in nausea and vomiting within 24 hours postoperatively,
showing success in a multitude of studies. Some noted gaps in research, however, include
the lack of monitoring and assessing patients for a full 24 hours postoperatively. Most
studies evaluated patients in an ambulatory setting, only monitoring their PONV status
between one and six hours (Smith et al., 2016). Lastly, studies have been difficult to
compare due to the various study designs and analyses performed (Thomas et al., 2019).
Designs, as well as inclusion criteria, differed from study to study. Kappen et al., (2015)
recommends to perform a project with the same design, analysis, and inclusion criteria in a
multi-campus health system as to adequately evaluate and critique the results.
The purpose of this DNP Project was to evaluate the implementation of a simplified
risk score and its ability to decrease the incidence of postoperative nausea and vomiting in
scheduled surgical patients.
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Chapter 3
Design
This project used a retrospective pre and post implementation quality improvement
design. This approach was chosen due to its success in other studies. Thomas, Maple,
Norcross, & Muckler (2019) utilized a pre and post implementation design yielding a
decrease in the incidence of postoperative nausea and vomiting (PONV). Additionally,
Smith, Haas, Zepp, & Klein (2016) proved the reduction of PONV in the PACU setting with
the use of a pre-and post-intervention design. The data for this project was collected from
the electronic health record (EHR) where it was documented that the patient experienced
nausea and/or vomiting in the post anesthesia care unit (PACU). The data collected during
the pre-implementation phase provided a baseline of PONV incidence. The post
implementation data was extracted similarly to the pre implementation phase. The pre and
post implementation data was compared and analyzed.
Setting
The setting for the practice change initiative occurred in a Mid-Atlantic urban, 506
bed hospital located in central Pennsylvania. The hospital is part of a large not-for-profit
healthcare organization that holds Magnet designation for nursing excellence.
Approximately 12,000 outpatient surgeries occur per year within the organization.
Participants in the setting were from the operative suite, focusing in the Perioperative
Surgical Home (where prescreening phone calls occur) and the following three areas where
participants may receive antiemetics: pre-procedure area, the operating room, and the PACU.
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Population/Sample
Subjects for this project were adult patients undergoing a scheduled surgery.
Inclusion criteria included English speaking patients 18 years of age and older. Subjects
were excluded for the following: pregnancy, admission to the intensive care unit after
surgery, and mechanical ventilation support overnight after surgery. The sample size for pre
implementation and post implementation needed to be approximately 350 subjects per group
to achieve statistical significance using a two-tailed sequential likelihood test. The factors
used to determine the sample size were the following: 99% confidence interval, expected
relative effect size of a 25% reduction in PONV, and a baseline PONV rate of 32% per
Thomas, Maple, Norcross, & Muckler (2019). All patients who met the criteria were
included in the project.
Data Collection
Every effort was made to protect the private health information of the subjects. In
order to ensure that patient confidentiality was protected, Institutional Review Board (IRB)
approval through West Chester University and the hospital was obtained and granted from
both institutions (Appendices A & B).
All data was de-identified during collection. Identification numbers were placed on
documentation forms and stored in a locked cabinet in a secured office in the hospital.
Informed consent was required, as this was not defined as a research study.
The collection of data occurred within the hospital’s existing electronic charting
system. The staff documented the presence of nausea and/or vomiting with the assessment
flowsheet portion of the EHR. Data was manually extracted regarding the flowsheet rows
specific to nausea and vomiting documentation.
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Instruments
After pre implementation data was collected, introduction of the Apfel Simplified
Risk Score for PONV was reviewed with the staff of the perioperative surgical home
department. The Apfel Simplified Risk Score for PONV objectively quantifies risks for
PONV and recommends prophylactic antiemetics based on the patient’s individual risk for
developing PONV (Thomas et al., 2019). The risk assessment tool assigns each risk factor
one point and the cumulative number of points equates to the patient’s individual risk for
PONV (Thomas et al., 2019). Risk factors include post-operative opioids, non-smoker,
female gender, and history of PONV/motion sickness. Scores are divided into low risk (0-1
points), moderate risk (2 points), and high risk (3 or more points). Scores can range from 0-4
with the corresponding risk for PONV to be 10%, 20%, 40%, 60%, and 80% respectively
(Thomas et al., 2019). Additionally, an algorithm links risk severity with treatment
recommendations.
Implementation
The primary investigator educated and supported nursing staff in assessing patients
for PONV by utilizing the Apfel Simplified Risk Score, specifically focusing on the criteria
of motion sickness. Education was provided in staff meetings and during informal
presentations/inservices to Perioperative Surgical Home (PSH) staff, PACU staff, and
anesthesia providers. The primary investigator and selected champions provided live support
during the implementation of the risk assessment tool. Registered nurses from the PSH who
screen patients via the telephone asked patients if they have had a history of motion sickness.
If the patient answered “yes” to motion sickness, the nurse entered “motion sickness” into the
patient’s past medical history as well as into a comment box labeled “HPI” (history of
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present illness) within the patient’s EHR. A second screening team consisting of two nurse
practitioners and one anesthesiologist reviewed the patient’s EHR. If a patient had been
identified as having motion sickness in the past, the second screening team called the patient
to inquire about the severity of the motion sickness and any treatments they had used in the
past to treat it. The second screening team used their discretion and clinical experience to
determine if a call to the patient was warranted. It was not guaranteed the patient would
receive a call. The second screening team referred treatment recommendations and orders to
the primary surgery team. For patients who screened “yes” for motion sickness, the second
screening team recorded the patient’s medical record number and date of surgery on a master
list (Appendix C). The master list was kept in a purple folder labeled “PONV Screening”
which was located on the second desk to the left within the Perioperative Surgical Home
Office. The primary investigator collected this on a regular basis.
The primary investigator collected data through a chart review of PONV in English
speaking, scheduled surgical patients 18 years of age and older within the project timeline. A
spreadsheet was utilized to collect and organize patient data (Appendix D). All identifying
patient information was de-identified and was included in the data collection. Each case was
evaluated for utilization of the Apfel tool, specifically the criteria of motion sickness, the
patient’s risk score according to the tool, and the incidence of PONV. Data collection took
place over a 6-week period.
Planning/Timeline
When planning this project, support for practice change came from key stakeholders.
The researcher met with the manager of anesthesia services, anesthesia providers, and staff
nurses in the operative suite to identify the processes that occurred during the practice
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change. Throughout the planning process, the primary investigator met with staff during
staff meetings to educate them on the project and protocol that was implemented. A timeline
was shared with staff and key stakeholders providing them with a guide of educational
sessions, roles of the nurses, roles of anesthesia providers, and dates of implementation (see
Appendix E).
Budget
The budget for this quality improvement project was minimal. The primary
investigator spent under $300 to feed staff members during inservices and educational
sessions. There was no direct incurred cost to the hospital. There was no cost for a
statistician.
Data Analysis
A categorical two-sample t test was conducted to ensure pre implementation and post
implementation groups were statistically equivalent. To identify a change in PONV
incidence pre/post implementation a two-tailed sequential likelihood test was used. An Alpha
of 0.05 was used.
Key Stakeholders
The main stakeholders of this project included, but were not limited to, patients who
had a scheduled outpatient surgery, the staff nurses within the PSH, the preoperative suite,
the operating room and the PACU, providers who worked within the PSH, such as two nurse
practitioners and one anesthesiologist, anesthesia providers, and hospital leaders who trusted
staff within the hospital to provide safe and effective care to patients.
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Plan for Dissemination to Key Stakeholders
The primary investigator discussed strengths, weaknesses, opportunities, and results
of this project with the staff and hospital leadership teams. A written report and PowerPoint
presentation was provided to show statistical findings. Recommendations were made for
future practice change.
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Chapter 4
Results
This project used a retrospective pre-and post- implementation quality improvement
design to determine if the use of a risk assessment tool led to a decrease in PONV rates. Preintervention results were collected between December 23, 2019 and February 2, 2020. There
were 12 participants in the pre-intervention group. Post-intervention results were collected
between February 3, 2020 and March 15, 2020. There were 16 participants in the postintervention group.
The null hypothesis was that there was no significant difference in the incidence of
postoperative nausea and vomiting between pre- and post-intervention of a risk assessment
tool in scheduled outpatient surgeries. For the pre-intervention group, 2 of the 12
participants (17%) experienced PONV. For the post-intervention group, 3 of the 16
participants (19%) experienced PONV.
The pre-intervention group consisted of 6 females and 6 males, and the postintervention group consisted of 14 females and 2 males. Pre-intervention males had a 17%
incidence of PONV, while zero post-intervention males experienced PONV. Seventeen
percent of females in the pre-intervention group experienced PONV and 21% of the females
in the post intervention group experienced PONV (Table 1). All participants in the preintervention group received general anesthesia, with 17% experiencing PONV (Table 2).
Eight percent of those who experienced PONV in the post-intervention group received
general anesthesia, while 67% of participants who experienced PONV in the postintervention group received spinal anesthesia (Table 2).
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Table 3 shows the distribution of PONV rates by the Apfel risk score. Of the
participants in the pre-intervention group, 25% of the participants with a risk score of zero
presented with PONV, and 25% of the participants with a risk score of two also experienced
PONV. In the post-intervention group, 20% of the participants with a score of two, 20%
with a score of three, and 20% with score of four experienced PONV.
Table 4 summarizes each risk factor for PONV. Participants may have zero, one or
multiple risk factors in both the pre and post intervention groups. In the pre-intervention
group, 17% of the participants who were female experienced PONV. In the post-intervention
group, 21% of the participants who were female experienced PONV. When referring to the
risk factor of a history of motion sickness and/or PONV, the pre-intervention group was not
consistently screened. One participant had this risk factor, yet no pre-intervention
participants with this risk factor experienced PONV. For the post intervention group, all
participants were screened for a history of motion sickness/PONV, and 20% of them
experienced PONV. Fourteen percent of participants in the pre-intervention group and 22%
in the post intervention group were non-smokers and also experienced PONV. Lastly, zero
participants in the pre-intervention group and 11% in the post intervention group who had a
risk factor for planned postoperative opioids experienced PONV.
Analysis
A two-tailed sequential likelihood test was used to identify a change in PONV
incidence. The PONV rate was 12.5% higher in the post-intervention group, with a p value of
0.433. The p value was greater than the chosen Alpha (0.05), meaning the null hypothesis
could not be rejected.
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A categorical two-sample t test was conducted to ensure pre implementation and post
implementation groups were statistically equivalent. The test was used to compare the
categorical results of the Apfel risk assessment score for pre and post intervention groups.
The null hypothesis assumed the means were equivalent. The test results had a mean score
of 1.3 in the pre-intervention group and a mean score of 2.9 in the post-intervention mean.
The t test had a p value of 0.001. The p value was less than Alpha of 0.05, thus rejecting the
null hypothesis and concluding that the population in the pre-intervention group was different
than the population in the post intervention group.
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Chapter 5
Discussion
Postoperative nausea and vomiting causes complications such as delayed healing
time, increased length of stay, and decreased patient satisfaction (Smith & Ruth-Sahd, 2016).
Various factors have been identified to increase one’s risk for developing PONV including
gender, a history of PONV or motion sickness, a history of non-smoking, and the use of
opioids postoperatively (Squire & Spencer, 2018). By implementing a risk assessment tool
to identify risk factors before surgery and treat the patient with appropriate antiemetics, the
rate of PONV may be decreased.
The purpose of this quality improvement project was to evaluate the implementation
of a simplified risk score and its ability to decrease the incidence of postoperative nausea and
vomiting in scheduled surgical patients. The key findings of this project were not ideal. Due
to a small sample size and varying populations between the pre and post-intervention groups,
the rate of PONV did not decrease.
Although the null hypothesis could not be rejected, this quality improvement project
did identify clinical significance among the participants who experienced PONV. Female
participants experienced PONV more frequently than male participants, a finding supported
in a study by Squire & Spencer (2018) (Table 1). Seventeen percent of participants who
experienced PONV in the pre-intervention group received general anesthesia. In the post
intervention group, 67% of those who experienced PONV received spinal anesthesia and
eight percent received general anesthesia (Table 2). According to Tabrizi et al. (2019),
patients tend to experience PONV when volatile anesthetics, such as those used in general
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anesthesia, are used. Completing a project in the future with a larger sample size may be
beneficial to further examine anesthesia types and their correlation to PONV.
The distribution of PONV rates by the Apfel risk score was difficult to compare
between the pre and post-intervention groups because participants in the pre-intervention
group were not consistently screened for motion sickness. When referring to the Apfel risk
score, low scores indicate a lower risk for PONV, whereas high scores, such as three or four,
indicate a higher risk for PONV (Apfel, Laara, Koivuranta, Greim, & Roewer, 1999). In the
pre-intervention group, participants with scores of zero and two did experience PONV. In
the post intervention group, participants who did experience PONV had scores of two, three,
and four (Table 3). Adding motion sickness to the prescreening phone call process did
identify participants who could be more at risk for PONV; however, it did not lead to an
increased use of antiemetic mediations preoperatively or an overall decrease in PONV rates
in this quality improvement project. When looking at each risk factor of PONV (female
gender, history of motion sickness/PONV, non-smoker, and planned postoperative use of
opioids), the quality improvement project was not able to identify statistically significant
findings (Table 4), though it did identify clinical significance as previously discussed.
Application of Theoretical Framework
This project correlates with Neuman Systems Model Prevention as Intervention. By
applying the Apfel Risk Assessment to participants during the intervention phase, including
the risk factor of motion sickness, primary prevention was instituted. Participants were
assessed for risk factors and identified for the potential of an increased risk for PONV.
When the nurses notified providers of the participants’ increased risk for PONV, the
secondary prevention phase occurred, allowing the providers the opportunity to intervene and
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promote the use of antiemetics before surgery. Neuman’s third phase, the tertiary prevention
phase, supports the wellness of participants’ experience after receiving antiemetics
prophylactically (Neuman & Fawcett, 2011). Although participants did not always receive
antiemetics prophylactically and the incidence of PONV did not decrease, participants’
overall wellness was still addressed and antiemetics were administered if PONV did occur.
Implications for Practice, Education, & Policy
This quality improvement project led to implications for both practice and policy
changes. Nursing education and possible changes to curriculum were evaluated, though
implications for changes were not indicated. Implications for practice include increased
communication between nursing and anesthesia providers. Nursing can communicate high
risk patients (scores of 3 or 4) to the anesthesia providers. Additionally, implementing a
prophylaxis protocol that anesthesia providers can utilize can be beneficial. Once the Apfel
risk score is identified, providers can tailor the use of antiemetics according to the patient’s
degree of risk for PONV.
Possible policy changes include the implementation of a policy on proper PONV
documentation for nursing staff. Nursing staff in the perioperative surgical home department
should be required to ask all patients if he/she has a history of motion sickness. This will
allow thorough and non-biased assessment and documentation for PONV for all scheduled
surgery patients. Also, a policy can be implemented regarding proper documentation of
PONV. There were inconsistencies regarding where within the EHR nurses should
document PONV. By instituting a policy, proper documentation can occur, reports can
accurately be extracted, and data can be appropriately analyzed.
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Limitations
The most notable limitation of this quality improvement project was the small sample
size. Data had been extracted manually, but due to a world-wide pandemic and policies of
strict social distancing, the primary investigator was unable to physically enter the hospital
and continue to manually collect data. The primary investigator analyzed the data that was
collected prior to the pandemic which resulted in a small sample size. Not having an
electronic report to collect the data was also a notable limitation for this project. Manually
extracting the data was time consuming and limited the number of participants, specifically
because of the pandemic. Additionally, the pre and post-intervention groups were not similar
in population. The post-intervention group was consistently screened for motion sickness
and the pre intervention group was not, creating a selection bias.
Another limitation that was noted with this quality improvement project included the
inconsistency of PONV documentation. Nurses in PACU and on inpatient units were not
consistently documenting PONV. Upon review of patients’ EHRs and their medication
administration records, it was noted that at times antiemetics were administered, yet it was
not consistently documented that PONV occurred. Additionally, some nurses in the PACU
were documenting PONV under a gastrointestinal focused assessment, while other nurses
were documenting it under a nutrition focused assessment. When the primary investigator
performed chart reviews to extract data, there were numerous places she needed to look to
identify if the patient experienced PONV.
Recommendations
A recommendation for future quality improvement projects is to replicate this project,
but have a larger sample size in order to maximize post-surgical outcomes. To obtain a
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larger sample size, the primary investigator should extract and analyze data on all surgical
patients; not just for those who could manually be extracted. By creating an electronic report
that extracts data, the primary investigator can more efficiently and effectively extract and
analyze data on all surgical patients. With an increase in sample size, it would be hopeful to
identify statistically significant findings as well as further validate clinical findings.
It is recommended to continue to preoperatively screen patients for motion sickness in
order to further evaluate the effects of the Apfel tool on overall PONV incidence. Nursing
can play a more integral role in a future project by regularly screening patients for all PONV
risk factors and by also consistently documenting and reporting PONV. Educating staff on
where to appropriately document PONV within the EHR will provide a more thorough and
robust project. Nursing can also advocate for their patients by verbally reporting high-risk
patients, those with a score of three or four, directly to anesthesia providers. By verbally
communicating this to the anesthesia providers, nursing can ensure the providers are aware.
Nursing can also recommend treatment options, such as the use of a scopolamine patch, an
antiemetic commonly used to prevent or decrease PONV.
Additionally, creating a compliance policy for anesthesia providers may benefit
future studies. By having anesthesia providers be responsible for following a protocol once
the Apfel risk score is identified, proper antiemetics can be administered, thus promoting a
possible decrease in PONV rates.
Conclusion
Postoperative nausea and vomiting is an ongoing complication post-surgery. With
the implementation of a risk assessment tool, at risk patients can be identified and
prophylactically treated. The outcomes of this project reinforce the need for collaborative
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care from various members of the healthcare team. By incorporating nurses and anesthesia
providers into the thorough assessment of patients and their risk factors, PONV can be more
closely analyzed and treated.
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Table 1
PONV Rates by Gender
Gender
Male
Female
Total

Pre-intervention
1 (17%, n=6)
1 (17%, n=6)
2 (17%, n=12)

Post-intervention
0 (0%, n=2)
3 (21%, n=14)
3 (19%, n=16)

Note. Percentages represent the percentage of participants who experienced PONV.
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Table 2
PONV Rates by Anesthesia Type
Anesthesia Type
General
Spinal
MAC
Total

Pre-intervention
2 (17%, n=12)
0 (0%, n=0)
0 (0%, n=0)
2 (17%, n=12)

Post-intervention
1 (8%, n=12)
2 (67%, n=3)
0 (0%, n=1)
3 (19%, n=16)

Note. Percentages represent the percentage of participants who experienced PONV.
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Table 3
PONV Rates by Apfel Risk Score
Apfel Risk Score
0
1
2
3
4
Total

Pre-intervention
1 (25%, n=4)
0 (0%, n=2)
1 (25%, n=4)
0 (0%, n=2)
0 (0%, n=0)
2 (17%, n=12)

Post-intervention
0 (0%, n=0)
0 (0%, n=1)
1 (20%, n=5)
1 (20%, n=5)
1 (20%, n=5)
3 (19%, n=16)

Note. Percentages represent the percentage of participants who experienced PONV.
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Table 4
PONV Rates by PONV Risk Factor Predictors
PONV Risk Factor Predictors
Female gender
History of motion sickness or
PONV
Nonsmoker
Postoperative opioids

Pre-intervention
1 (17%, n=6)

Post-intervention
3 (21%, n=14)

0 (0%, n=1)
1 (14%, n=7)
0 (0%, n=2)

3 (20%, n=15)
2 (22%, n=9)
1 (11%, n=9)

Note. Percentages represent the percentage of participants who experienced PONV.
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Figure 1

Primary

Reduce Risk
Factors: Assess
patients for
PONV risk

Secondary

Intervention:
Implement
prophylactic
antiemetics, if
applicable

Tertiary

Protection and
Support:
Support the
patient’s
wellness during
the acute
recovery phase

Figure 1.
Neuman Systems Model, Prevention as Intervention applied to risk assessment and
prophylaxis protocol regarding PONV (Neuman & Fawcett, 2011).
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Appendices
Appendix A: Institutional Review Board Approval, West Chester University
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Appendix B: Institutional Review Board Approval, Hospital
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Appendix C: Master List for Positive Motion Sickness
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Appendix D: Data Collection Spreadsheet
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Appendix E: Proposed Timeline
November 2019-January 2020
•
•
•
•
•
•
•
•

Researcher will meet with key stakeholders and clinical staff to obtain support
Researcher will learn the workflow of the nurses and anesthesia providers in the
surgical suite
Researcher will meet with preceptor to discuss details of the project
Submit IRB application to WCU
Submit IRB application to proposed hospital site
Gather retrospective data (6 weeks-worth)
Obtain champions to help implement practice change
Educate staff on the practice change and use of the Apfel Risk Assessment Score,
specifically motion sickness

February 2020 – March 2020
•
•
•
•
•

Meet with champions to address any barriers
Continue educational sessions and inservices regarding implementation
Implement the use of the Apfel Risk Assessment Score, specifically motion sickness
Gather data and begin interpreting results with a statistician
Complete interpretation of results

April 2020
•
•

Meet with champions and manager to addresses changes/revisions for future practice
Present findings/results to hospital administration
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